Search Results - "Brail, L. H."

Gene expression in individual cells : analysis using global single cell reverse transcription polymerase chain reaction (GSC RT-PCR) by BRAIL, L. H, JANG, A, BILLIA, F, ISCOVE, N. N, KLAMUT, H. J, HILL, R. P

“…The determination of the gene expression pattern of single cells has important implications for many areas of cellular and developmental biology including…”
Get full text

A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours by Hollebecque, Antoine, Houédé, Nadine, Cohen, Ezra E.W, Massard, Christophe, Italiano, Antoine, Westwood, Paul, Bumgardner, William, Miller, Joel, Brail, Les H, Benhadji, Karim A, Soria, Jean-Charles

“…Abstract Background LY2584702 tosylate (hereafter referred to as LY2584702) is an oral, selective ATP competitive inhibitor of p70 S6 kinase. Preclinical…”
Get full text

A phase I dose-escalation and pharmacokinetic (PK) evaluation of an oral AKT inhibitor, LY2503029 (LY) by Limentani, S. A., Burris, H., Anderson, A. P., Brail, L. H., Satonin, D., Gueorguieva, I., Jones, S., Infante, J. R., Bendell, J. C.

“…Abstract only…”
Get full text

A phase I dose-escalation, pharmacokinetic (PK), and pharmacodynamic (PD) evaluation of intravenous LY2090314 a GSK3 inhibitor administered in combination with pemetrexed and carboplatin by Brail, L. H., Gray, J. E., Burris, H., Simon, G. R., Cooksey, J., Jones, S. F., Farrington, D., Lam, T., Jackson, K., Chow, K., Brandt, J. T., Infante, J. R.

“…Abstract only…”
Get full text

Randomized phase II trial of cisplatin/gemcitabine with or without LY293111, a multiple eicosonaid pathway modulator, in patients with chemotherapy naïve advanced non-small cell lung carcinoma by Janne, P. A., Paz-Ares Rodriguez, L., Gottfried, M., Reaume, M. N., Kaukel, T., Oh, Y. W., Sykes, A., Enas, N., Brail, L. H., Von Pawel, J.

“…Abstract only 7024 Background: The eicosanoid pathway is altered in NSCLC. Pharmacological activators of peroxisome proliferator-activated receptor-gamma…”
Get full text

Clonal heterogeneity in plasminogen activator activity produced by two murine tumor cell lines by Brail, L H, Hill, R P

“…Secretion of plasminogen activators (PA) has been shown to be an important method by which cells can initiate degradation of the extracellular matrix (ECM). In…”
Get full text